title: [Ovarian metastasis of breast cancer: a case report. Role of cytoreductive surgery].
abstract: The ovaries are a common metastatic site for breast cancer. The diagnosis and treatment of ovarian masses from a metastatic breast cancer are difficult. The complete resection of these metastatic masses seems to give a benefit in terms of global survival. This benefit depends on the residual tumoral volume and on the free interval between initial breast cancer diagnosis and apparition of the metastatic ovarian masses. We discuss the treatment of a patient with ovarian metastasis as first sign of a metastatic breast cancer.
authors.affiliation: Service de gynécologie, site hôpital Sainte-Thérèse, grand hôpital de Charleroi ASBL, 6061 Montignies-sur-Sambre, Belgique. duboisnathanael@yahoo.fr
authors.forename: N
authors.initials: N
authors.lastname: Dubois
authors.forename: T
authors.initials: T
authors.lastname: Willems
authors.forename: N
authors.initials: N
authors.lastname: Myant
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000097:blood; D001943:Breast Neoplasms / Q000473:pathology* / Q000628:therapy*; D018275:Carcinoma, Lobular / Q000188:drug therapy / Q000473:pathology* / Q000556:secondary*; D003520:Cyclophosphamide / Q000627:therapeutic use; D015251:Epirubicin / Q000627:therapeutic use; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D015412:Mastectomy, Segmental; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000556:secondary*
chemical_list: D014408:Biomarkers, Tumor; D015251:Epirubicin; D003520:Cyclophosphamide; D005472:Fluorouracil